Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
19h
AZoLifeSciences on MSNCRISPR-Cas9 Off-Target Effects: Challenges and SolutionsThe CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...
The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
2d
New Vision on MSNMagoola says cancer treatment invention awarded US patentKAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...
In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
Africa is grappling with severe food insecurity in the wake of consecutive droughts, climate change, and ongoing conflicts, which are affecting millions across the continent.
Both Cas9 and Cas12a cleave DNA, but they differ in how they cut the molecule.
a novel Cas enzyme approximately one third the size of Cas9 ? which can be easily accommodated ... life-threatening and debilitating diseases. Founded by CRISPR pioneer and Nobel laureate Jennifer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results